Targeting the secondary bile acid glycodeoxycholic acid as therapeutic strategy in type 2 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 31 May 2018
Price : $35 *
At a glance
- Drugs Ezetimibe (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TRADE
- 31 May 2018 Planned number of patients changed from 32 to 40.
- 08 Mar 2018 New trial record